Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2026-01-02 @ 12:34 PM
Study NCT ID:
NCT02277769
Status:
COMPLETED
Last Update Posted:
2020-06-02
First Post:
2014-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2015-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-27
First Submit QC Date:
None
Study First Post Date:
2014-10-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-16
Results First Submit QC Date:
None
Results First Post Date:
2017-10-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-01-13
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-05-21
Last Update Post Date:
2020-06-02
Last Update Post Date Type:
ACTUAL